Background-Insulin has been shown to exert positive inotropic effects in several in vitro and in vivo models, but signal transduction and substrate dependency remain unclear. We examined inotropic responses and signal transduction mechanisms of insulin in human myocardium. Methods and Results-Experiments were performed in isolated trabeculae from end-stage failing hearts of 58 nondiabetic and 3 diabetic patients undergoing heart transplantation. The effect of insulin (0.3 and 3 IU/L) on isometric twitch force (37°C, 1 Hz) was tested in the presence of glucose or pyruvate as energetic substrate. Furthermore, intracellular Ca 2ϩ transients (aequorin method), sarcoplasmic reticulum (SR) Ca 2ϩ content (rapid cooling contractures), and myofilament Ca 2ϩ sensitivity (semiskinned fibers) were assessed. In addition, potential signaling pathways were tested by blocking glycolysis, PI-3-kinase, protein kinase C, diacylglycerol kinase, insulin-like growth factor-1 receptors, or transsarcolemmal Ca 2ϩ entry via the Na ϩ /Ca 2ϩ exchanger. Insulin exerted concentration-dependent and partially substrate-dependent positive inotropic effects. The phosphatidylinositol-3-kinase inhibitor wortmannin and the Na 2ϩ /Ca 2ϩ exchanger reverse-mode inhibitor KB-R7943 completely or partially prevented the functional effects of insulin. In contrast, insulin-like growth factor-1 receptor blockade, protein kinase C inhibition, and diacylglycerol kinase blockade were without effect. The inotropic response was associated with increases in intracellular Ca 2ϩ transients, SR Ca 2ϩ content, and increased myofilament Ca 2ϩ sensitivity.
Conclusions-Insulin exerts Ca2ϩ -dependent and -independent positive inotropic effects through a phosphatidylinositol-3-kinase-dependent pathway in failing human myocardium. The increased [Ca 2ϩ ] i originates at least in part from enhanced reverse-mode Na ϩ /Ca 2ϩ exchange and consequently increased SR-Ca 2ϩ load. These nongenomic functional effects of insulin may be of clinical relevance, eg, during insulin-glucose-potassium infusions. Key Words: insulin Ⅲ calcium Ⅲ heart failure Ⅲ myocardium Ⅲ contractility P atients with chronic heart disease often have insulin resistance, diabetes, or altered glucose metabolism. 1 Insulin, a polypeptide of 51 amino acids, is known to regulate serum glucose levels, protein synthesis, and growth. Effects of insulin on myocardial function have been tested in several animal models under in vitro and in vivo conditions, and controversial results with both enhanced contractility and myocardial performance [2][3][4][5][6] or no functional effects 7,8 have been reported. Insulin infusions improved ventricular function in one study in humans 9 but had no effect in another. 10 In addition, the functional response to insulin may be different in diabetic versus nondiabetic animals 3,11,12 and humans. 9,13 Recently, the onset of insulin resistance has been shown to coincide with progression from pressure-overload hypertrophy to dilatation. 14 Whole-body insulin resistance is prevalent i...